# Medtronic plc (MDT) FY2024 Annual P&L / Income Statement

- Company: Medtronic plc (MDT)
- Period: 2023-04-29 to 2024-04-26
- Filing: FY2024 10-K, filed 2024-06-20, accession number 0001613103-24-000072
- Page: https://plicit.ai/financials/mdt/fy2024-annual-income-statement
- Chart image: https://plicit.ai/charts/mdt-fy2024-annual-income-statement-sankey.png

## Chart details: Revenue by Business Segment by Subsegment

Income statement for 2023-04-29 through 2024-04-26. View: Segments by Subsegments. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 32,364,000,000 US dollars
- **Cost of products sold, excluding amortization of intangible assets**: 11,216,000,000 US dollars
- **Gross profit (calculated)**: 21,148,000,000 US dollars
- **Operating costs, including other operating expenses (calculated)**: 16,003,000,000 US dollars
- **Operating profit**: 5,144,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 307,000,000 US dollars
- **Income before income taxes**: 4,837,000,000 US dollars
- **Income tax provision**: 1,133,000,000 US dollars
- **Net income**: 3,705,000,000 US dollars
- **Diabetes**: 2,488,000,000 US dollars
- **Other operating segment**: 221,000,000 US dollars
- **Cardiovascular - Cardiac Rhythm & Heart Failure**: 5,995,000,000 US dollars
- **Cardiovascular - Coronary & Peripheral Vascular**: 2,478,000,000 US dollars
- **Cardiovascular - Structural Heart & Aortic**: 3,358,000,000 US dollars
- **Medical Surgical - Acute Care & Monitoring**: 1,908,000,000 US dollars
- **Medical Surgical - Surgical & Endoscopy**: 6,508,000,000 US dollars
- **Neuroscience - Cranial & Spinal Technologies**: 4,756,000,000 US dollars
- **Neuroscience - Neuromodulation**: 1,746,000,000 US dollars
- **Neuroscience - Specialty Therapies**: 2,905,000,000 US dollars
- **Undisclosed (calculated)**: 1,000,000 US dollars
- **Research and development expense**: 2,735,000,000 US dollars
- **Selling, general, and administrative expense**: 10,736,000,000 US dollars
- **Amortization of intangible assets**: 1,693,000,000 US dollars
- **Restructuring charges, net**: 226,000,000 US dollars
- **Certain litigation charges, net**: 149,000,000 US dollars
- **Other operating expense (income), net**: 464,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- The amounts that make up operating profit come to $5,145.00 M and operating profit is $5,144.00 M; the $1.00 M difference is within the rounding of the filed amounts.
- The amounts that make up net income come to $3,704.00 M and net income is $3,705.00 M; the $1.00 M difference is within the rounding of the filed amounts.

## Chart details: Revenue by Geography

- Page: https://plicit.ai/financials/mdt/fy2024-annual-income-statement/revenue-by-geography
- Chart image: https://plicit.ai/charts/mdt-fy2024-annual-revenue-by-geography-sankey.png

Income statement for 2023-04-29 through 2024-04-26. View: Geography (Schedule of Net Sales to External Customers and Property, Plant, and Equipment, Net, by Geographic Region). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 32,364,000,000 US dollars
- **Cost of products sold, excluding amortization of intangible assets**: 11,216,000,000 US dollars
- **Gross profit (calculated)**: 21,148,000,000 US dollars
- **Operating costs, including other operating expenses (calculated)**: 16,003,000,000 US dollars
- **Operating profit**: 5,144,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 307,000,000 US dollars
- **Income before income taxes**: 4,837,000,000 US dollars
- **Income tax provision**: 1,133,000,000 US dollars
- **Net income**: 3,705,000,000 US dollars
- **UNITED STATES**: 16,562,000,000 US dollars
- **Rest of world**: 15,689,000,000 US dollars
- **IRELAND**: 113,000,000 US dollars
- **Research and development expense**: 2,735,000,000 US dollars
- **Selling, general, and administrative expense**: 10,736,000,000 US dollars
- **Amortization of intangible assets**: 1,693,000,000 US dollars
- **Restructuring charges, net**: 226,000,000 US dollars
- **Certain litigation charges, net**: 149,000,000 US dollars
- **Other operating expense (income), net**: 464,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- The amounts that make up operating profit come to $5,145.00 M and operating profit is $5,144.00 M; the $1.00 M difference is within the rounding of the filed amounts.
- The amounts that make up net income come to $3,704.00 M and net income is $3,705.00 M; the $1.00 M difference is within the rounding of the filed amounts.

## Chart details: Revenue by Business Segment

- Page: https://plicit.ai/financials/mdt/fy2024-annual-income-statement/revenue-by-business-segment
- Chart image: https://plicit.ai/charts/mdt-fy2024-annual-revenue-by-business-segment-sankey.png

Income statement for 2023-04-29 through 2024-04-26. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 32,364,000,000 US dollars
- **Cost of products sold, excluding amortization of intangible assets**: 11,216,000,000 US dollars
- **Gross profit (calculated)**: 21,148,000,000 US dollars
- **Operating costs, including other operating expenses (calculated)**: 16,003,000,000 US dollars
- **Operating profit**: 5,144,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 307,000,000 US dollars
- **Income before income taxes**: 4,837,000,000 US dollars
- **Income tax provision**: 1,133,000,000 US dollars
- **Net income**: 3,705,000,000 US dollars
- **Cardiovascular**: 11,831,000,000 US dollars
- **Neuroscience**: 9,406,000,000 US dollars
- **Medical Surgical**: 8,417,000,000 US dollars
- **Diabetes**: 2,488,000,000 US dollars
- **Other operating segment**: 221,000,000 US dollars
- **Undisclosed (calculated)**: 1,000,000 US dollars
- **Research and development expense**: 2,735,000,000 US dollars
- **Selling, general, and administrative expense**: 10,736,000,000 US dollars
- **Amortization of intangible assets**: 1,693,000,000 US dollars
- **Restructuring charges, net**: 226,000,000 US dollars
- **Certain litigation charges, net**: 149,000,000 US dollars
- **Other operating expense (income), net**: 464,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- The amounts that make up operating profit come to $5,145.00 M and operating profit is $5,144.00 M; the $1.00 M difference is within the rounding of the filed amounts.
- The amounts that make up net income come to $3,704.00 M and net income is $3,705.00 M; the $1.00 M difference is within the rounding of the filed amounts.

## Chart details: Revenue by Geography (2)

- Page: https://plicit.ai/financials/mdt/fy2024-annual-income-statement/revenue-by-geography-2
- Chart image: https://plicit.ai/charts/mdt-fy2024-annual-revenue-by-geography-2-sankey.png

Income statement for 2023-04-29 through 2024-04-26. View: Geography (Disaggregation of Net Sales by Market Geography for Each Segment). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 32,364,000,000 US dollars
- **Cost of products sold, excluding amortization of intangible assets**: 11,216,000,000 US dollars
- **Gross profit (calculated)**: 21,148,000,000 US dollars
- **Operating costs, including other operating expenses (calculated)**: 16,003,000,000 US dollars
- **Operating profit**: 5,144,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 307,000,000 US dollars
- **Income before income taxes**: 4,837,000,000 US dollars
- **Income tax provision**: 1,133,000,000 US dollars
- **Net income**: 3,705,000,000 US dollars
- **UNITED STATES**: 16,562,000,000 US dollars
- **Non-U.S. Developed Markets**: 9,979,000,000 US dollars
- **Emerging Markets**: 5,823,000,000 US dollars
- **Research and development expense**: 2,735,000,000 US dollars
- **Selling, general, and administrative expense**: 10,736,000,000 US dollars
- **Amortization of intangible assets**: 1,693,000,000 US dollars
- **Restructuring charges, net**: 226,000,000 US dollars
- **Certain litigation charges, net**: 149,000,000 US dollars
- **Other operating expense (income), net**: 464,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- The amounts that make up operating profit come to $5,145.00 M and operating profit is $5,144.00 M; the $1.00 M difference is within the rounding of the filed amounts.
- The amounts that make up net income come to $3,704.00 M and net income is $3,705.00 M; the $1.00 M difference is within the rounding of the filed amounts.